ShanghaiBio Corporation Partners with Ingenuity Systems
News Sep 10, 2012
ShanghaiBio Corporation and Ingenuity® Systems have signed a collaboration agreement enabling ShanghaiBio Corporation to extend its current lab service offering to include Ingenuity solutions for downstream analysis and interpretation of genomics data. ShanghaiBio Corporation will complement their sequencing, genotyping and gene expression lab services by creating a bundled solution with Ingenuity’s applications, which combine analytics and biomedical content to help get actionable insights from experiments.
ShanghaiBio Corporation, one of leading genomics and biomarker service providers with all integrated microarray/Next generation sequencing/PCR/biobanking/pathology capabilities based in China and US, supports global pharmaceutical and biotechnology companies’ and academic institutes’ drug discovery efforts specifically in the areas of translational medicine and systems biology. By offering Ingenuity products, ShanghaiBio Corporation supports the complete workflow from study design to bioinformatic analysis, providing its customers with high-quality data and easily interpretable results.
Jason Jin, CEO of ShanghaiBio Corporation, stated, “China is rapidly expanding its investment in the innovative life sciences, drug R&D, and molecular diagnostics sectors. Many organizations including pharmaceutical companies, biotech firms and universities have growing programs for translational medicine research and are faced with analyzing and understanding complex data. With Ingenuity’s solutions, we are helping our customers rapidly obtain a detailed assessment of their data so they can move to the next phase of their research.”
High throughput experiments generate a significant amount of data, and obtaining insights from that data can be a time-consuming, laborious process. Ingenuity’s suite of products, based on the Ingenuity Knowledge Base repository of biological interactions and functional annotations created from the peer-reviewed literature, help researchers interpret the biological meaning of their data.
Dr. Hong Wang, a ShanghaiBio’s collaborator and Assistant Professor from Rutgers University, explained, "The Ingenuity iReport analysis tool is essential in helping us understand the biological implications for our gene expression research projects. It is easy to use, and we can get the result within a few hours after we submit the raw data."
CRISPR Used to Prevent Development of Angiogenesis of the RetinaNews
Powerful new technology may lead to novel therapies to prevent vision loss, blindness in those with diseases of the retina.READ MORE
Comments | 0 ADD COMMENT
6th Edition of International Conference on Pharmacognosy and Medicinal Plants
Apr 16 - Apr 17, 2018